Loading live market data…

Danaher Corporation

NYSE:DHR

$199.05 USD

-$1.11 (-0.55%)

Volume
4.19M
Average Volume
4.65M
Market Capitalization
$140.88B
P/E Ratio
38.35
Dividend Yield
0.72%
Price Target
$230.00
Year High
$242.80
Year Low
$160.93
Day High
—
Day Low
—
Payout Ratio
$0.25
Current Ratio
$1.87

Industry, Sector & symbol

Stock Exchange NYSE
CEO Rainer Blair
Industry Medical - Diagnostics & Research
Sector Healthcare
Current Symbol DHR
CUSIP 235851102
CIK 0000313616
Web https://www.danaher.com
Phone 202 828 0850
Currency USD
Employees 61000
Country US

Liquidity

Debt-to-Equity Ratio 0.35
Payout Ratio 0.25
Current Ratio 1.87
Quick Ratio 1.52
Cash Ratio 0.76

Sales & Book Value

Annual Sales $24.57B
Price / Sales 5.69
Cash Flow 7.47
Price / Cash Flow 26.63
Price / Book 2.66

Price Target and Rating

Average Stock Price Forecast $230.00
High Stock Price Forecast $249.00
Low Stock Price Forecast $200.00
Forecast Upside/Downside -13.46%
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 43 Analysts

Profitability

EPS (Most Recent Fiscal Year) $5.04
Trailing P/E Ratio 38.35
PEG Ratio 1727247602751632.80
P/E Growth 1727247602751632.80
Net Income $3.61B
Net Margin 14.89%
Pretax Margin 17.51%
Return on Equity 7.06%
Return on Assets 4.42%

Financials Score

AltmanZ Score 4.13
Piotroski Score 6.00
Working Capital 6.48B
Total Assets 83.54B
Ebit 4.6B
Market Cap 140.88B
Total Liabilities 30.6B

Poll Results

About Danaher Corporation (NYSE:DHR) Stock

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers ... bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Implied Volatility Surging for Danaher Stock Options

2026-07-14 16:41:20

Investors need to pay close attention to DHR stock based on the movements in the options market lately.

Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth

2026-07-14 11:01:06

Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abbott Labs Vs. Danaher: Abbott's Everyday Products Beat Danaher's Slumping Biotech Equipment

2026-07-10 14:18:48

Abbott Laboratories (NYSE:ABT | ABT Price Prediction) and Danaher (NYSE:DHR) both closed the books on Q1 2026 with very different stories.

VTRS or DHR: Which Is the Better Value Stock Right Now?

2026-07-09 12:40:44

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?

2026-07-08 12:51:04

Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

2026-07-07 10:31:24

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

2026-07-03 12:26:00

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa

2026-06-29 08:30:00

WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP). The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground.

Frequently Asked Questions

What is the current Danaher Corporation (DHR) stock price?

Danaher Corporation(NYSE:DHR) stock price is $199.05 in the last trading session. During the trading session, DHR stock reached the peak price of $242.8 while $160.93 was the lowest point it dropped to. The percentage change in DHR stock occurred in the recent session was --0.55% while the dollar amount for the price change in DHR stock was -$-1.11.

DHR's industry and sector of operation?

The NYSE listed DHR is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of DHR?

Rachel Marie Vatnsdal Olson | Vice President of Investor Relations
Martin Stumpe | Chief Technology & AI Officer
Rainer Blair | President, Chief Executive Officer & Director
Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform
Mitchell Rales | Co-Founder & Director

How many employees does DHR have?

Number of DHR employees currently stands at 61000. DHR operates from 2200 Pennsylvania Avenue, NW, Washington, DC 20037-1701, US.

Link for DHR official website?

Official Website of DHR is: https://www.danaher.com

How do I contact DHR?

DHR could be contacted at phone #202 828 0850 and can also be accessed through its website. DHR operates from 2200 Pennsylvania Avenue, NW, Washington, DC 20037-1701, US.

How many shares of DHR are traded daily?

The average number of DHR shares traded daily for last 3 months was 4.65M.

What is the market cap of DHR currently?

The market value of DHR currently stands at $140.88B with its latest stock price at $199.05